Pharmaceutical enterprises in the field op medical equipment and life sciences are facing big challenges as a result of increasing pressure from health care. The global demand for innovative and affordable medicines continues to grow. Simultaneously legislators, payers, healthcare providers and patients want better value for money, proved efficiency of products, greater transparency and access to data. To meet these demands enterprises are seeking ways to increase the productivity of their R&D departments, to work more efficiently, make the sale and marketing expenditures more transparent, and reinforce the financial results.
In consultation with our customers, varying from small entrepreneurs in the field of life sciences to large multinationals, we seek to increase the results by improving the efficiency and effectivity around the companies’ main activities.
Trustworthy PwC advisors use their sector experience, knowledge and expertise to help our clients in the whole value chain of the pharmaceutical and life sciences industry to help judging strategic business opportunities, improve management and supervision and signaling savings initiatives.
Revitalizing Pharmaceutical R&D: The value of real world evidence
In The Netherlands we have a broad team of devoted professionals with specific attention to our different regions. This covers both the sector itself and the knowledge institutions, including the universities of Amsterdam, Leiden, Utrecht, Eindhoven and Maastricht, and the innovative business parks like Amterdam Biomed, Leiden Bioscience, Utrecht Sciencepark, Pivotpark Oss and Healthcampus Maastricht. Due to these specific local attention we built a proven record of service in building bridges within the sector in a proactive manner.
Peter Paul Hoek
Director, PwC Netherlands
Tel: +31 (0)88 792 59 14
Director Assurance, PwC Netherlands
Tel: +31 (0)88 792 14 42
© 2015 - 2020 PwC. PwC. All rights reserved. PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure for further details.